Meili Nanotechnology Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2017

Location

Shenzhen Guangdong China

Primary Industry

Medical Devices & Equipment

About

Established in 2017 and based in Shenzhen, China, Meili Nanotechnology operates as a nanopore early cancer detection devices developer that provides commercial gene sequencing instruments and supporting reagents. The core research team comes from Ohio State University, University of Washington, University of Jena, Germany and University of Chinese Academy of Sciences. The company cooperates with institute of physics of Chinese Academy of Sciences, Shenzhen University of Technology and Xiangya Hospital of Central South University, etc. In March 2021, the company cooperates with Changde high-tech zone. In November 2022, it was rewarded as the top 10 most growing biotech companies. In February 2023, the company raised closed series A+ round of funding led by Antubio. The company combines nanopore gene sequencing technology with pathogen detection. Products cover many testing fields, including immunological, microbiological, biochemical, molecular and coagulation, etc. Its products include MePore single-channel sequencing systems for research users, MeMob gene sequencers, MeZero pA class current amplifier and multichannel microfluidic chips.

Current Investors

Beijing Tongtrong Investment, JuCreate, Autobio Diagnostics Co., Ltd

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment, Diagnostic Equipment

Website

www.meilitech.cn

Verticals

HealthTech, Manufacturing

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.